Featured Research

from universities, journals, and other organizations

Caffeine Use To Regulate Breathing Of Very Preterm Babies, Long-term Benefits

Date:
November 8, 2007
Source:
McMaster University
Summary:
Caffeine and similar drugs have been used for more than 30 years to make the breathing of very preterm babies more regular, but without sufficient knowledge of the possible benefits and risks. Caffeine has been found to reduce the rates of cerebral palsy and cognitive delay.

Very premature babies who were given caffeine to regulate their breathing have a significantly lower incidence of disabilities at the age of two years, according to an international study led by researchers at McMaster University.

Related Articles


Researchers studied more than 2000 premature babies who were either treated with caffeine or given a placebo. The latest results of this large clinical trial will appear in the Nov. 8 issue of the New England Journal of Medicine (NEJM). Babies receiving the caffeine were less likely to develop cerebral palsy and cognitive delay.

Caffeine and similar drugs have been used for more than 30 years to make the breathing of very preterm babies more regular, but without sufficient knowledge of the possible benefits and risks.

The study involved infants who weighed between 500 and 1250 grams at birth, and who were at risk of apnea -- interrupted or irregular breathing due to immaturity. The ongoing study, with colleagues in Canada, Australia, the US, Europe and Israel, will continue to follow the children until they reach the age of five. The project is funded by the Canadian Institutes of Health Research and the National Health and Medical Research Council of Australia.

According to Dr. Barbara Schmidt, the principal investigator of the research project, the latest results of the study showed that 46 percent of the infants receiving the placebo died or survived with a neurodevelopmental disability. Among the babies receiving caffeine therapy, only 40 percent had an unfavourable outcome by the time they reached the end of their second year of life.

"It definitely gives hope to parents," Dr. Schmidt concluded. "Of all the drugs we use in the neonatal intensive care unit, caffeine is the first to have been shown conclusively to reduce long-term disability in very preterm babies." Caffeine reduced the rates of cerebral palsy and cognitive delay but had no significant effect on the rates of death, bilateral blindness and severe hearing loss.

"This international study provides important follow-up to the earlier results reported by Dr. Schmidt and her colleagues and should have a major impact on the treatment and prevention of apnea in preterm infants," said Dr. Michael Kramer, Scientific Director of the CIHR Institute of Human Development, Child and Youth Health.

The Caffeine for Apnea of Prematurity (CAP) project enrolled 2006 premature infants who were born between October 1999 and October 2004 in nine countries. The research project was designed to address long-standing concerns about possible adverse effects of caffeine therapy in pre-term infants. All children will be re-assessed at five years to obtain more precise information on their development as they approach school age.

Apnea occurs in about 85 per cent of infants who are born at less than 34 weeks gestation. For more than 30 years, therapies known as methylxanthines, including caffeine, have been used to reduce the frequency of apnea and the need for mechanical ventilation. However, it has remained uncertain whether the use of methylxanthines has any additional benefits or risks in premature infants.

Earlier findings released last year by the same research team revealed that babies who received caffeine had a lower incidence of abnormal lung development than infants who were given a placebo.

Dr. Schmidt said that half of the beneficial treatment effect at two years of age was explained by the fact that babies receiving caffeine therapy came off ventilators sooner. "Ventilation is a double-edged sword," she said. "While it is life-saving, at the same time, it causes injury -- scarring the immature lung which is very susceptible to damage."

At McMaster, Dr. Schmidt is a part-time professor in the department of clinical epidemiology and biostatistics of the Michael G. DeGroote School of Medicine. She is also a professor of pediatrics at the University of Pennsylvania School of Medicine and will hold the inaugural Kristine Sandberg Knisely Chair in Neonatology at the Children's Hospital of Philadelphia.


Story Source:

The above story is based on materials provided by McMaster University. Note: Materials may be edited for content and length.


Cite This Page:

McMaster University. "Caffeine Use To Regulate Breathing Of Very Preterm Babies, Long-term Benefits." ScienceDaily. ScienceDaily, 8 November 2007. <www.sciencedaily.com/releases/2007/11/071107170755.htm>.
McMaster University. (2007, November 8). Caffeine Use To Regulate Breathing Of Very Preterm Babies, Long-term Benefits. ScienceDaily. Retrieved March 6, 2015 from www.sciencedaily.com/releases/2007/11/071107170755.htm
McMaster University. "Caffeine Use To Regulate Breathing Of Very Preterm Babies, Long-term Benefits." ScienceDaily. www.sciencedaily.com/releases/2007/11/071107170755.htm (accessed March 6, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, March 6, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Newsy (Mar. 5, 2015) A survey of Boston mothers and toddlers found that 15 percent of two-year-olds drink coffee and 2.5 percent of 1-year-olds. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins